LABTRACE.ORG BETA LIVE
240 source polls this hour 61 749 articles collected last article 2m ago 1092 events on 2+ sources 0 embeddings/h feed queue 0 lag 312.7s
← all events
LT-031467 / first seen 2026-10-14 14:25 / last activity 1h ago

Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial

measurement

heat
45 / 100 (raw 1.2)
velocity
0.0 independent sources per hour
solidity
80 / 100
sources
1 total, 1 independent
domain span
1 domain covered it

primary source

title
Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial
venue
status
peer-reviewed
doi
10.1016/s2213-8587(26)00136-1
published
2026-10-01